A Safety Study of Two Intratumoural Doses of Coxsackievirus Type A21 in Melanoma Patients (PSX-X03)

Clinical trial NCT00438009 · COMPLETED

Trial details

NCT number: NCT00438009
Sponsor: Viralytics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Stage IV Melanoma

Start date: 2007-05-16
Primary completion: 2009-08-28
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.